February 25, 2004 – The medical community took note recently when it was announced that experts from around the world with L-arginine had licensed her patented product, given the synergy Worldwide, a Nutraceutical company in Provo, Utah . The L-arginine patent is the invention of the renowned researcher, Dr. Ann Be the Allen, head of biomedical research to the Glycemic Research Institute in Washington, DC After 20 years of study of L-arginine, it was assumed that Dr.

Allen would license its patent for a major pharmaceutical company. Pharmaceutical companies and patent negotiations ended abruptly when the debate was announced that Synergy world had been granted patent rights L-arginine. Dr. Allen L-arginine patent is considered the breakthrough product of this century, and is currently worth 100 million dollars. The value of the patent is based on the unique qualities of Dr. Allen's formula.

Since the Nobel was awarded for the nitric oxide / L-arginine industry, nutraceutical and pharmaceutical industry are eager to bring L-arginine on the market. Scientists believe that the problem is that nobody seems to know enough about the L-arginine in a product that is effective and safe for human use to produce. From L-arginine has been proven in over 10,000 clinical trials to provide health benefits, the main advantage of L-arginine appears to be the reactivation of anti-aging required is complex and precise formulation.

Dr. Allen, โ € œYou can not just add L-arginine in a capsule or spray, or a formula that does not contain the proper co-factor, and expect them to work. That will not happen. L-arginine is both dose-dependent and timing-dependent, and is very selective, which cross the blood-brain barrier, where it releases hormones anti-aging. โ € researchers agree that L-arginine formulas containing Lysine, sucrose, maltodextrin, and any other officer of the competition does not.

L-arginine also reactivates the virus herpes simplex virus (HSV), and produces nitric oxide (NO), which can cause serious damage from free radicals. The methodology used for the production of L-arginine product that does not have these reactions was developed by Dr. Allen. When reporters asked Mr. Allen and synergy in the world, reveal these processes to the medical and scientific refused, saying that the process is โ € œproprietary, and is not described in the patent.

โ € One of the secrets revealed by chemical treatment of working on the project, the extraction of organic Kiwi glycosides and low glycemic carbohydrates that are not linked to molecules of L-arginine. Synergy Worldwide has announced the name of the product L-arginine is ProArgi-9, which will be launched in mid-February 2004.

Tags : anti aging, arginine, arginine patent, arginine product, l arginine, l arginine patent, l arginine product, nitric oxide, patent, synergy worldwide
Categories : Business